About MACROGEN
HUMANIZING
GENOMICS
Creating a better future for humanity
Corporate Status
EST 1997
Macrogen has maintained sustainable growth by adapting to changes in the environment.
As an industry leader with a strong influence on the bio-ecosystem, our journey to sustainable growth will continue.
  • 유전체 분석 건수 $130M Revenue¹
  • Bio Ventures Listed on KOSDAQ 50% Global Sales Ratio¹
  • Revenue (2017) 153 Countries 18,000+ customers
  • Overseas Revenue 600+ No. of employees at
    Global Macrogen²
  • Market Share Research Sequencing No.1
    market share
    in the Korean
    DNA Sequencing Industry
  • Countries 18K+ Global Partners Global
    TOP5
    The annual DNA
    Sequencing capacity:
    300,000 people per year
  • Nature Papers 30PB Big data computing
    infrastructure
  • Companies Assistance to Bio Venture 148 No. of published articles³

1) Based on Consolidated Financial Statements of 2021
2) As of March 2022
3) No. of SCI-level articles (including articles published in Nature and its affiliated journals)
Business Areas
Research Areas
We provide a wide range of research services for the development of genome-sequencing technology. Based on big data and advanced AI analytics accumulated through research, we are paving the way for a healthy future.
  • NGS
    NGS
  • CES
    CES
  • OlIGO
    OLIGO
  • MICROARRAY
    MICROARRAY
  • GEM
    GEM
  • BIOINFORMATICS
    BIOINFORMATICS
Business Areas
CLINICAL DIAGNOSTICS & TREATMENTS
We provide various clinical diagnoses and treatment for 7.8 billion people around the world. We are also committed to building a systematic diagnosis system to promote prediction and cause analysis of diseases.
  • 암유전체검사
    Cancer Occurrence Monitoring
  • 태아 및 희귀질환 검사
    Genetic Disorder
  • COVID-19
    COVID-19
Business Areas
PERSONAL HEALTHCARE & Pets
Based on big data and AI analytics built based on our extensive research, we provide personalized health care services based on DNA and health care solutions for companion animals.
  • Personal Genome Analysis
    Personal Genome Analysis
  • Microbiome Analysis
    Microbiome Analysis
  • Pets gene analysis
    Pets gene analysis
RESEARCH RESEARCH
Government, Universities and Research Centers
Our core areas of business include sequencing (NGS, CES), Microarray, Oligo, GEM (Genetically Engineered Mouse), and Bioinformatics in the form of biotechnology and clinical research service.
CLINICAL DIAGNOSTICS & TREATMENTS CLINICAL
DIAGNOSTICS &
TREATMENTS
For Patients and Medical Staff
We invest and conduct R&D projects in the field of precision medicine. This includes tests for cancer genomes, prenatal genomes, and rare disease genomes, focusing on providing personalized diagnosis, treatment, and health care solutions.
PERSONAL HEALTHCARE PERSONAL
HEALTHCARE
For the Public
As a key area of personal health care, genome services are gaining attention. Macrogen is providing more practical and effective health care solutions to improve the quality of people's lives through personal genomic analysis service "My Genome Story" and personalized healthcare solution "The Biome" based on microbiome testing and analysis.
PETS PETS
For Pets
myPETGENE™ is a genetic testing service for pets. We also analyze the genomic information of all living creatures including humans.
CI
Macrogen's CI represents
our commitment to a healthy life.
Macrogen CI
Macrogen is an abbreviation of Macroscopic Phenotype of Gene, representing our company that studies macroscopic phenomena or phenotypes of genes in vivo.

It symbolizes the realization of personalized medicine based on personal genomic information and our commitment to healthy human life in line with our slogan, "Humanizing Genomics."
COLOR SYSTEM
  • RGB 0 30 98
    CMYK 100 80 0 50
    HEX 001E62
  • RGB 0 191 178
    CMYK 80 0 40 0
    HEX 00BFB2
  • RGB 132 189 0
    CMYK 50 0 100 0
    HEX 84BD00
  • RGB 224 0 77
    CMYK 0 100 50 0
    HEX E0004D
Macrogen
Company Profile
TOP